Sector: Health Care
Director information for OPTION CARE HEALTH INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Barbara W. Bodem | Independent Director | 58 | ["Interim Chief Financial Officer of DENTSPLY Sirona Inc.","Senior Vice President and Chief Financial Officer of Hill-Rom Holdings, Inc.","Senior Vice President, Finance, of Mallinckrodt plc","Vice President, Global Commercial Finance of Hospira","Positions of increasing responsibility at Eli Lilly & Company","Extensive finance, accounting, and risk management experience","Significant healthcare industry experience","Experience with corporate governance matters, risk management, and management oversight"] | ["Audit and Finance Committee","Compensation Committee","Audit and Finance","Nominating and Corporate Governance"] | 2026 |
| Christopher L. Grashoff | Chief Growth Officer | 46 | ["Over 20 years of global healthcare experience","Experience at Baxter and Eli Lilly & Co.","Holds a B.A. in economics from DePauw University","Holds an M.B.A. from Harvard Business School"] | [] | 2026 |
| Elizabeth D. Bierbower | Independent Director | 67 | ["Chairman and Chief Executive Officer of Friday Health Plans (2022-2023)","Various leadership roles at Humana, including Segment President (2018-2020), President of Employer Group Segment (2012-2018), Chief Operating Officer of Specialty Benefits (2008-2012), and Vice President of Product Innovation (2001-2008)","Strategic leadership, operational experience and financial expertise with over 30 years of executive-level experience in healthcare","Served on several boards of directors of publicly- and privately-held companies"] | ["Audit and Finance Committee","Compensation Committee","Audit and Finance","Quality, Technology and Compliance"] | 2026 |
| Eric K. Brandt | Independent Director | 63 | ["Chief Financial Officer of Broadcom Inc., a Fortune 500 technology company (2007-2016)","President and Chief Executive Officer of Avanir Pharmaceuticals, Inc., a pharmaceutical manufacturing company (2005-2007)","Positions of increasing responsibility at Allergan Inc, a publicly-traded pharmaceutical manufacturing company, including as its Chief Financial Officer (1999-2005)","Vice President and Partner, The Boston Consulting Group, Inc. (1989-1999)","Significant business development and corporate strategy experience gained through executive leadership roles, including serving as chief executive officer and chief financial officer at multiple companies in the healthcare industry","Digital and technology experience gained through his leadership of the information technology department at a Fortune 500 technology company","Served in leadership roles on several public company boards, gaining valuable public company governance experience"] | ["Compensation Committee","Nominating and Corporate Governance Committee","Compensation","Quality, Technology and Compliance"] | 2026 |
| Femi Adewunmi, M.D. | Chief Medical Officer | 52 | ["More than 17 years of executive leadership experience managing healthcare operations","Experience at Carelon Health, Sound Physicians, and UNC Health","25 years of experience as a health care provider specializing in internal medicine and hospital medicine","Holds an M.D. in internal medicine from the University of Ibadan in Nigeria","Holds an M.B.A. from the Fuqua School of Business at Duke University"] | [] | 2026 |
| Harry M. Jansen Kraemer, Jr. | Director; Independent Board Chair | 71 | ["Clinical Professor of Management and Strategy at the Kellogg School of Management at Northwestern University (2005-Present)","Executive Partner of MDP, a private equity firm (2005-2025)","Chairman (2000-2004), President (1997-2004) and Chief Executive Officer (1999-2004) of Baxter International Inc.","Certified Public Accountant","Over 30 years of executive leadership experience","Extensive financial expertise and significant experience with boards of directors","Expertise in the healthcare industry and with technology and innovation"] | ["Audit and Finance Committee","Quality, Technology and Compliance Committee","Audit and Finance","Nominating and Corporate Governance (Chair)"] | 2026 |
| John C. Rademacher | Director; President and Chief Executive Officer | 59 | ["President and Chief Executive Officer, Option Care Health (2018-Present)","Chief Operating Officer, Option Care Health (2015-2018)","President, Ambulatory Care (2012-2014)","President, Nuclear & Pharmacy Services (2007-2012) of Cardinal Health, Inc.","Senior Vice President of Cigna (2001-2007)","Over 25 years of executive leadership experience in the healthcare industry"] | [] | 2026 |
| Meenal A. Sethna | Chief Financial Officer | 56 | ["Certified public accountant","Previous roles at Littelfuse, Inc., Illinois Tool Works Inc., Motorola Inc., and Baxter","B.A. from the University of Illinois-Urbana","M.B.A. from the Kellogg School of Management at Northwestern University"] | ["audit committee","governance & sustainability committee"] | 2026 |
| Natasha Deckmann, M.D. | Independent Director | 49 | ["Chief Executive Officer (2025-Present) of Tivity Health, Inc.","President (2024-2025) of Tivity Health, Inc.","Chief Transformation Officer (2024) of Tivity Health, Inc.","Chief Operating Officer, Chief Clinical Officer, and Board Member of SecureSeniorConnections (2020-2023)","Chief Executive Officer of CarePoint Health System (2018-2020)","Senior Vice President, Population Health Solutions and Chief Operating Officer, Consumer Solutions Group at Optum (2013-2018)","Positions at Marsh Inc. (2006-2012), including Chief Operating Officer of Marsh International"] | ["Quality, Technology and Compliance Committee","Nominating and Corporate Governance","Quality, Technology and Compliance"] | 2026 |
| Norman L. Wright | Independent Director | 61 | ["Positions of increasing responsibility at UnitedHealth, including as EVP, Health Equity Strategy (2022-2023); EVP and Chief Customer Experience Officer (2021-2022); EVP, Chief Marketing and Customer Experience Officer, Optum (2019-2021); and SVP and Chief of Global Operations (2013-2016)","Served in executive roles at Citigroup Inc., Accenture plc, Home Shopping Network, Inc., Fidelity Investments, and The General Electric Company","Nearly 40 years of experience as an executive in sales and customer service, operations, marketing, digital, and business consulting supporting a number of industries, including the healthcare industry","Significant experience in human capital management and risk management through his leadership of large, complex organizations","Has led large equity and community engagement strategies and has developed numerous global strategic plans, which bring value to our ESG and sustainability initiatives"] | ["Quality, Technology and Compliance Committee","Compensation","Nominating and Corporate Governance"] | 2026 |
| R. Carter Pate | Independent Director | 71 | ["Chief Executive Officer, Modivcare Inc. (2017-2020)","Chief Executive Officer, MV Transportation, Inc. (2011-2014)","Global and U.S. Managing Partner, Health Care and Government Services Practice, PricewaterhouseCoopers (1996-2012)","Extensive executive leadership and public company corporate governance experience","Financial expertise as a former managing partner of an international accounting firm","Experience with government relations, public policy and risk management","Understanding of the home and alternate site infusion industry"] | ["Audit and Finance"] | 2026 |
| Timothy P. Sullivan | Independent Director | 68 | ["Significant executive and human capital management experience obtained through his creation and leadership of one of the world’s leading private equity firms","Created significant stockholder value through acquisitions, divestitures and other transactions involving numerous portfolio companies in the healthcare industry","Extensive governance expertise gained through his current and prior service on the boards of several healthcare companies and leading non-profit organizations"] | ["Compensation Committee","Compensation"] | 2026 |
